ADPT — Adaptogenics Health Balance Sheet
0.000.00%
- CA$0.33m
- CA$0.26m
- CA$0.00m
Annual balance sheet for Adaptogenics Health, fiscal year end - March 31st, CAD millions except per share, conversion factor applied.
2022 March 31st | 2023 March 31st | 2024 March 31st | 2025 March 31st | |
---|---|---|---|---|
Period Length: | — | — | — | — |
Source: | PROSPECTUS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final |
Cash | ||||
Cash and Equivalents | ||||
Cash and Short Term Investments | 0.534 | 0.262 | 0.149 | 0.08 |
Net Total Accounts Receivable | ||||
Net Total Receivables | 0.004 | 0.004 | 0.005 | 0.003 |
Prepaid Expenses | ||||
Total Current Assets | 0.578 | 0.303 | 0.154 | 0.084 |
Total Assets | 0.578 | 0.303 | 0.154 | 0.084 |
Payable / Accrued | ||||
Notes Payable / Short Term Debt | ||||
Total Other Current Liabilities | ||||
Total Current Liabilities | 0.048 | 0.039 | 0.022 | 0.027 |
Total Long Term Debt | ||||
Total Debt | ||||
Total Liabilities | 0.048 | 0.039 | 0.022 | 0.027 |
Common Stock | ||||
Retained Earnings (Accumulated Deficit) | ||||
Total Equity | 0.529 | 0.264 | 0.132 | 0.058 |
Total Liabilities & Shareholders' Equity | 0.578 | 0.303 | 0.154 | 0.084 |
Total Common Shares Outstanding |